Aurobindo Pharma is currently trading at Rs. 442.75, up by 5.50 points or 1.26% from its previous closing of Rs. 437.25 on the BSE. The scrip opened at…
Aurobindo Pharma is currently trading at Rs. 583.95, up by 3.55 points or 0.61% from its previous closing of Rs. 580.40 on…
Aurobindo Pharma has reported results for second quarter ended September 30, 2018. The company has reported a fall of 49.40% in its…
Aurobindo Pharma’s wholly owned subsidiary — Aurobindo Pharma USA Inc. — has entered into an agreement to acquire a product under development…
